A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : WIN / WIN 55,212-2 mesylate

[Related PubMed/MEDLINE]
Total Number of Papers: 6
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   WIN  (>> Co-occurring Abbreviation)
Long Form:   WIN 55,212-2 mesylate
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2alpha and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats. CBP, eIF2, PP1
2017 Rapid quantification of neutral lipids and triglycerides during zebrafish embryogenesis. ORO, Rimo, TLC
2016 Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. AEDs, CB, i.p, PEA
2016 The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets. MMPs, RA, SF
2014 Influence of WIN 55,212-2 on the anticonvulsant and acute neurotoxic potential of clobazam and lacosamide in the maximal electroshock-induced seizure model and chimney test in mice. CLB, LCM, MES
2004 Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat. ---